BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11324983)

  • 1. In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye.
    Babiole M; Wilhelm F; Schoch C
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):159-72. PubMed ID: 11324983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites of isopropyl unoprostone as potential ophthalmic solutions to reduce intraocular pressure in pigmented rabbits.
    Kashiwagi K; Iizuka Y; Tsukahara S
    Jpn J Pharmacol; 1999 Sep; 81(1):56-62. PubMed ID: 10580371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
    Chien DS; Tang-Liu DD; Woodward DF
    J Pharm Sci; 1997 Oct; 86(10):1180-6. PubMed ID: 9344177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
    Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
    Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human ocular distribution of bimatoprost and latanoprost.
    Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
    Bito LZ; Baroody RA
    Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro.
    Madhu C; Rix P; Nguyen T; Chien DS; Woodward DF; Tang-Liu DD
    J Ocul Pharmacol Ther; 1998 Oct; 14(5):389-99. PubMed ID: 9811228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.
    Sunkara G; Deruiter J; Clark CR; Kompella UB
    J Pharm Pharmacol; 2000 Sep; 52(9):1113-22. PubMed ID: 11045892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration into the anterior chamber via the conjunctival/scleral pathway.
    Schoenwald RD; Deshpande GS; Rethwisch DG; Barfknecht CF
    J Ocul Pharmacol Ther; 1997 Feb; 13(1):41-59. PubMed ID: 9029439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
    Tirucherai GS; Dias C; Mitra AK
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue.
    Hellberg MR; Ke TL; Haggard K; Klimko PG; Dean TR; Graff G
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):97-103. PubMed ID: 12804054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and ex vivo hydrolysis rates of ethacrynate esters and their relationship to intraocular pressure in the rabbit eye.
    Deshpande G; Schoenwald RD; Barfknecht CF; Duffel MW
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):539-56. PubMed ID: 11132901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of prostaglandin F2 alpha metabolism by human ocular tissues.
    Cheng-Bennett A; Poyer J; Weinkam RJ; Woodward DF
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1389-93. PubMed ID: 2365570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.
    Chien DS; Sasaki H; Bundgaard H; Buur A; Lee VH
    Pharm Res; 1991 Jun; 8(6):728-33. PubMed ID: 2062802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of topical ocular phenylephrine HCl.
    Antoine ME; Edelhauser HF; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1984 Jan; 25(1):48-54. PubMed ID: 6698730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro.
    Davies SS; Ju WK; Neufeld AH; Abran D; Chemtob S; Roberts LJ
    J Ocul Pharmacol Ther; 2003 Feb; 19(1):45-54. PubMed ID: 12648303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracameral anesthesia: in vitro iris and corneal uptake and washout of 1% lidocaine hydrochloride.
    Anderson NJ; Woods WD; Kim T; Rudnick DE; Edelhauser HF
    Arch Ophthalmol; 1999 Feb; 117(2):225-32. PubMed ID: 10037568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
    Grove J; Gautheron P; Plazonnet B; Sugrue MF
    J Ocul Pharmacol; 1988; 4(4):279-90. PubMed ID: 3246565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro.
    Basu S; Sjöquist B; Stjernschantz J; Resul B
    Prostaglandins Leukot Essent Fatty Acids; 1994 Apr; 50(4):161-8. PubMed ID: 8022849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.